(Q54576022)

1 June 2018

title

Efficacy and safety of once-daily amikacin in combination with ceftazidime in critically ill adults with severe gram-negative infections. (English)

1 reference

1 June 2018

1 reference

1 reference

Fayed DF

1

1 reference

1 June 2018

Dahmash NS

2

1 reference

1 June 2018

al-Zeer AH

3

1 reference

1 June 2018

Shibl AM

4

1 reference

1 June 2018

Huraib SO

5

1 reference

1 June 2018

Abu-Aisha H

6

1 reference

1 June 2018

publication date

1 December 1996

1 reference

1 June 2018

published in

Journal of Chemotherapy

1 reference

1 June 2018

volume

8

1 reference

1 June 2018

issue

6

1 reference

1 June 2018

page(s)

457-464

1 reference

1 June 2018

A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.6.457

Once-daily aminoglycoside therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.6.457

Determinants of efficacy and toxicity of aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.6.457

Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.6.457

First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.6.457

A study of amikacin given once versus twice daily in serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.6.457

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.6.457

Once versus thrice daily gentamicin in patients with serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.6.457

Pharmacokinetics of a 3 mg/kg body weight loading dose of gentamicin or tobramycin in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.6.457

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.6.457

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.6.457

Aminoglycoside nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.6.457

21 January 2018

Identifiers

DOI

10.1179/JOC.1996.8.6.457

1 reference

1 June 2018

PubMed ID

8981187

1 reference

1 June 2018